Monroe Cap Q2 2024 Adj. EPS $0.31 Beats $0.25 Estimate, Sales $15.627M Beat $15.220M Estimate
Portfolio Pulse from Benzinga Newsdesk
Monroe Capital (NASDAQ: MRCC) reported Q2 2024 adjusted EPS of $0.31, beating the $0.25 estimate by 24%. Sales were $15.627M, surpassing the $15.220M estimate by 2.67%, but down 4.40% from $16.347M last year.
August 07, 2024 | 9:54 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Monroe Capital (NASDAQ: MRCC) reported Q2 2024 adjusted EPS of $0.31, beating the $0.25 estimate by 24%. Sales were $15.627M, surpassing the $15.220M estimate by 2.67%, but down 4.40% from $16.347M last year.
The significant beat on EPS and slight beat on sales estimates are positive indicators for the stock in the short term. However, the year-over-year decline in sales may temper some of the enthusiasm.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100